A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace.
The best Bull and Bear pitches based on recency and number of recommendations.
I've watched Medicines' ascent from the sidelines but after reviewing the stock again this week I've decided to follow the story more closely with a green thumb. Angiomax revenues have remained solid, although I'm concerned regarding ongoing… More
TheStreet.com: "There still seems to be a lot of hope built into the stock price. As Morgan Stanley analyst Stephen Herr wrote this week, "if the patent life is not extended, this stock looks broadly overvalued."
Read the most recent pitches from players about MDCO.DL.
Find the members with the highest scoring picks in MDCO.DL.
See what the Wall Street professionals think, according to their public statements and filings.